Identification of functional DNA variants in the constitutive promoter region of MDM2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-7364
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Identification of functional DNA variants in the constitutive promoter region of MDM2 ; volume:6 ; number:1 ; day:1 ; month:9 ; year:2012 ; pages:1-7 ; date:12.2012
Human genomics ; 6, Heft 1 (1.9.2012), 1-7, 12.2012
- Urheber
-
Lalonde, Marie-Eve
Ouimet, Manon
Larivière, Mathieu
Kritikou, Ekaterini A.
Sinnett, Daniel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1479-7364-6-15
- URN
-
urn:nbn:de:101:1-2021081522035204798806
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lalonde, Marie-Eve
- Ouimet, Manon
- Larivière, Mathieu
- Kritikou, Ekaterini A.
- Sinnett, Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Mining and application of constitutive promoters from Rhodosporidium toruloides
MDM2 negatively regulates the human telomerase RNA gene promoter
A toolset of constitutive promoters for metabolic engineering of Rhodosporidium toruloides
Biochemical and physiological analysis of oncogenic constitutive active variants of gp130
Biochemical and physiological analysis of oncogenic constitutive active variants of gp130
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
Definition of constitutive and stage-enriched promoters in the rodent malaria parasite, Plasmodium yoelii
Functional analysis of recurrent CDC20 promoter variants in human melanoma
MDM2 splice variants : cellular localization and expression in a transgenic mouse model
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Mining and application of constitutive promoters from Rhodosporidium toruloides
MDM2 negatively regulates the human telomerase RNA gene promoter
A toolset of constitutive promoters for metabolic engineering of Rhodosporidium toruloides
Biochemical and physiological analysis of oncogenic constitutive active variants of gp130
Biochemical and physiological analysis of oncogenic constitutive active variants of gp130
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
Definition of constitutive and stage-enriched promoters in the rodent malaria parasite, Plasmodium yoelii
Functional analysis of recurrent CDC20 promoter variants in human melanoma
MDM2 splice variants : cellular localization and expression in a transgenic mouse model
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Mining and application of constitutive promoters from Rhodosporidium toruloides
MDM2 negatively regulates the human telomerase RNA gene promoter
A toolset of constitutive promoters for metabolic engineering of Rhodosporidium toruloides
Biochemical and physiological analysis of oncogenic constitutive active variants of gp130
Biochemical and physiological analysis of oncogenic constitutive active variants of gp130
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
Definition of constitutive and stage-enriched promoters in the rodent malaria parasite, Plasmodium yoelii
Functional analysis of recurrent CDC20 promoter variants in human melanoma
MDM2 splice variants : cellular localization and expression in a transgenic mouse model